NCT00592943View on ClinicalTrials.gov

PET Study Examining the Dopaminergic Activity of Armodafinil in Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2010

Conditions
Healthy
Interventions
DRUG

armodafinil

tablet, taken by mouth, once each study day

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00592943 - PET Study Examining the Dopaminergic Activity of Armodafinil in Adults | Biotech Hunter | Biotech Hunter